Incidencia y factores de riesgo asociados con nefropatía inducida por medios de contraste en procedimientos intervencionistas de cardiología

Autores:
Garnica Benincore, Paola
Fuentes París, Sergio
Sanabria Ardila , Miguel
Espinosa Marrugo, Cristian
Rosselli San Martin, Carlos
Osorio Gómez, Nelson William
Tipo de recurso:
Article of journal
Fecha de publicación:
2019
Institución:
Fundación Universitaria de Ciencias de la Salud - FUCS
Repositorio:
Repositorio Digital Institucional ReDi
Idioma:
spa
OAI Identifier:
oai:repositorio.fucsalud.edu.co:001/2333
Acceso en línea:
https://repositorio.fucsalud.edu.co/handle/001/2333
https://doi.org/10.31260/RepertMedCir.v28.n3.2019.958
Palabra clave:
Insuficiencia renal aguda
Medios de contraste
Angiografía coronaria
Medicina Interna
Acute renal insufficiency
Contrast media
Coronary angiography
Rights
openAccess
License
https://creativecommons.org/licenses/by-nc-sa/4.0/
id FUCS2_cd6a270634e35bf1e843521fe19b8b53
oai_identifier_str oai:repositorio.fucsalud.edu.co:001/2333
network_acronym_str FUCS2
network_name_str Repositorio Digital Institucional ReDi
repository_id_str
dc.title.spa.fl_str_mv Incidencia y factores de riesgo asociados con nefropatía inducida por medios de contraste en procedimientos intervencionistas de cardiología
dc.title.translated.eng.fl_str_mv Incidence and risk factors of contrast-induced nephropathy in interventional cardiology procedures
title Incidencia y factores de riesgo asociados con nefropatía inducida por medios de contraste en procedimientos intervencionistas de cardiología
spellingShingle Incidencia y factores de riesgo asociados con nefropatía inducida por medios de contraste en procedimientos intervencionistas de cardiología
Insuficiencia renal aguda
Medios de contraste
Angiografía coronaria
Medicina Interna
Acute renal insufficiency
Contrast media
Coronary angiography
title_short Incidencia y factores de riesgo asociados con nefropatía inducida por medios de contraste en procedimientos intervencionistas de cardiología
title_full Incidencia y factores de riesgo asociados con nefropatía inducida por medios de contraste en procedimientos intervencionistas de cardiología
title_fullStr Incidencia y factores de riesgo asociados con nefropatía inducida por medios de contraste en procedimientos intervencionistas de cardiología
title_full_unstemmed Incidencia y factores de riesgo asociados con nefropatía inducida por medios de contraste en procedimientos intervencionistas de cardiología
title_sort Incidencia y factores de riesgo asociados con nefropatía inducida por medios de contraste en procedimientos intervencionistas de cardiología
dc.creator.fl_str_mv Garnica Benincore, Paola
Fuentes París, Sergio
Sanabria Ardila , Miguel
Espinosa Marrugo, Cristian
Rosselli San Martin, Carlos
Osorio Gómez, Nelson William
dc.contributor.author.spa.fl_str_mv Garnica Benincore, Paola
Fuentes París, Sergio
Sanabria Ardila , Miguel
Espinosa Marrugo, Cristian
Rosselli San Martin, Carlos
Osorio Gómez, Nelson William
dc.subject.spa.fl_str_mv Insuficiencia renal aguda
Medios de contraste
Angiografía coronaria
Medicina Interna
topic Insuficiencia renal aguda
Medios de contraste
Angiografía coronaria
Medicina Interna
Acute renal insufficiency
Contrast media
Coronary angiography
dc.subject.eng.fl_str_mv Acute renal insufficiency
Contrast media
Coronary angiography
publishDate 2019
dc.date.accessioned.none.fl_str_mv 2019-10-25 00:00:00
2022-02-21T20:36:26Z
dc.date.issued.none.fl_str_mv 2019-10-25
dc.date.available.none.fl_str_mv 2019-10-25 00:00:00
2022-02-21T20:36:26Z
dc.type.spa.fl_str_mv Artículo de revista
dc.type.eng.fl_str_mv Journal article
dc.type.coar.fl_str_mv http://purl.org/coar/resource_type/c_2df8fbb1
dc.type.coar.spa.fl_str_mv http://purl.org/coar/resource_type/c_6501
dc.type.driver.spa.fl_str_mv info:eu-repo/semantics/article
dc.type.version.spa.fl_str_mv info:eu-repo/semantics/publishedVersion
dc.type.content.spa.fl_str_mv Text
dc.type.coarversion.spa.fl_str_mv http://purl.org/coar/version/c_970fb48d4fbd8a85
format http://purl.org/coar/resource_type/c_6501
status_str publishedVersion
dc.identifier.doi.none.fl_str_mv 10.31260/RepertMedCir.v28.n3.2019.958
dc.identifier.issn.none.fl_str_mv 0121-7372
dc.identifier.uri.none.fl_str_mv https://repositorio.fucsalud.edu.co/handle/001/2333
dc.identifier.eissn.none.fl_str_mv 2462-991X
dc.identifier.url.none.fl_str_mv https://doi.org/10.31260/RepertMedCir.v28.n3.2019.958
identifier_str_mv 10.31260/RepertMedCir.v28.n3.2019.958
0121-7372
2462-991X
url https://repositorio.fucsalud.edu.co/handle/001/2333
https://doi.org/10.31260/RepertMedCir.v28.n3.2019.958
dc.language.iso.spa.fl_str_mv spa
language spa
dc.relation.references.spa.fl_str_mv Parfrey P. The clinical epidemiology of contrast-induced nephropathy. Cardiovasc Intervent Radiol. 2005;28 Suppl 2:S3-11. 2. Brar S, Aharonian V, Mansukhani P, et al. Haemodynamic guided fluid for the administration for the prevention of contrast-induced acute kidney injury. The POSEIDON randomized controlled trial . Lancet 2014; 383:1814-23 3. Crimi G, et al. Incidence, pronostic impact and optimal definition of contrast-induced acute kidney injury in consecutive patients with stable or unstable coronary artery disease undergoing percutaneous coronary intervention. Insights from the all-comer PRODIGY trial. Catheter cardiovasc interv. 2015; 86(1):19-27 4. Rihal CS, Textor SC, Grill DE, Berger PB, Ting HH, Best PJ, et al. Incidence and prognostic importance of acute renal failure after percutaneous coronary intervention. Circulation. 2002;105(19):2259-64. 5. Solomon R, Werner C, Mann D, D'Elia J, Silva P. Effects of saline, mannitol, and furosemide on acute decreases in renal function induced by radiocontrast agents. N Engl J Med. 1994;331(21):1416-20. 6. Barrett BJ, Parfrey PS. Prevention of nephrotoxicity induced by radiocontrast agents. N Engl J Med. 1994;331(21):1449-50. 7. Tepel M, van der Giet M, Schwarzfeld C, Laufer U, Liermann D, Zidek W. Prevention of radiographic-contrast-agent-induced reductions in renal function by acetylcysteine. N Engl J Med. 2000;343(3):180-4. 8. Shyu KG, Cheng JJ, Kuan P. Acetylcysteine protects against acute renal damage in patients with abnormal renal function undergoing a coronary procedure. J Am Coll Cardiol. 2002;40(8):1383-8 9. Reza khatami m, nikravan n, salari-far m, davoudi s, et al. A comparison of definitions of contrast-induced nephropathy in patients with normal serum creatinine. Saudi j kidney dis transpl. 2016; 27(1):94-100. 10. Acosta k, Romero J. Cambios recientes en las principales causas de mortalidad en Colombia. Documentos de Trabajo Sobre Economía Regional es una publicación del Banco de la República de Colombia número 209, octubre 2014. 11. Caiazza A, Russo L, Sabbatini M, Russo D. Hemodynamic and tubular changes induced by contrast media. Bio med research international. 2014; 2014:578974. doi: 10.1155/2014/578974 12. Gruberg L, Mehran R, Dangas G, Mintz GS, Waksman R, Kent KM, et al. Acute renal failure requiring dialysis after percutaneous coronary interventions. Catheter Cardiovasc Interv. 2001;52(4):409-16. 13. Tziakas D, Chalikias G, stakos D, et al. Validation of the new risk score to predict contrast-induced nephropathy after percutaneous coronary intervention. Am J cardiol. 2014; 113: 1487-93 14. McCullough PA, Adam A, Becker CR, Davidson C, Lameire N, Stacul F, et al. Risk prediction of contrast-induced nephropathy. Am J Cardiol. 2006;98(6A):27K-36K. 15. Zhang B, Liang L, Chen W, et al. The efficacy of sodium bicarbonate in preventing contrast-induced nephropathy in patients with pre-existing renal insufficiency: a meta analysis. BMJ open. 2015; 5(3): 1-12. 16. Iakovou I, Dangas G, Mehran R, Lansky AJ, Ashby DT, Fahy M, et al. Impact of gender on the incidence and outcome of contrast-induced nephropathy after percutaneous coronary intervention. J Invasive Cardiol. 2003;15(1):18-22. 17. Bouzas-Mosquera A, Vázquez-Rodríguez JM, Calviño-Santos R, Peteiro-Vázquez J, Flores-Ríos X, Marzoa-Rivas R, et al. [Contrast-induced nephropathy and acute renal failure following emergent cardiac catheterization: incidence, risk factors and prognosis]. Rev Esp Cardiol. 2007;60(10):1026-34. 18. Weisbord SD, Gallagher M, Jneid H, Garcia S, Cass A, Thwin SS, et al. Outcomes after Angiography with Sodium Bicarbonate and Acetylcysteine. N Engl J Med. 2018;378(7):603-14. 19. McCullough PA, Choi JP, Feghali GA, Schussler JM, Stoler RM, Vallabahn RC, et al. Contrast-Induced Acute Kidney Injury. J Am Coll Cardiol. 2016;68(13):1465-73. 20. Scharnweber T, Alhilali L, Fakhran S. Contrast-Induced Acute Kidney Injury: Pathophysiology, Manifestations, Prevention, and Management. Magn Reson Imaging Clin N Am. 2017;25(4):743-53. 21. Madsen TE, Pearson RR, Muhlestein JB, Lappé DL, Bair TL, Horne BD, et al. Risk of nephropathy is not increased by the administration of larger volume of contrast during coronary angiography. Crit Pathw Cardiol. 2009;8(4):167-71. 22. Carnevalini M, et al. Nefropatía por constraste en el síndrome coronario agudo. Medicina. 2011; 71(5):441-448. 23. Nikolsky E, Mehran R, Lasic Z, Mintz GS, Lansky AJ, Na Y, et al. Low hematocrit predicts contrast-induced nephropathy after percutaneous coronary interventions. Kidney Int. 2005;67(2):706-13. 24. Freeman RV, O'Donnell M, Share D, Meengs WL, Kline-Rogers E, Clark VL, et al. Nephropathy requiring dialysis after percutaneous coronary intervention and the critical role of an adjusted contrast dose. Am J Cardiol. 2002;90(10):1068-73. 25. Garfinkle M, et al. Incidence of CT contrast agent- induced nephropathy a more accurate estimation. AJR. 2015; 204: 1146-51 26. Roy P, Raya V, Okabe T, Pinto Slottow TL, Steinberg DH, Smith K, et al. Incidence, predictors, and outcomes of post-percutaneous coronary intervention nephropathy in patients with diabetes mellitus and normal baseline serum creatinine levels. Am J Cardiol. 2008;101(11):1544-9. 27. Rear R, Bell RM, Hausenloy DJ. Contrast-induced nephropathy following angiography and cardiac interventions. Heart. 2016;102(8):638-48. 28. Tsai TT, Patel UD, Chang TI, Kennedy KF, Masoudi FA, Matheny ME, et al. Contemporary incidence, predictors, and outcomes of acute kidney injury in patients undergoing percutaneous coronary interventions: insights from the NCDR Cath-PCI registry. JACC Cardiovasc Interv. 2014;7(1):1-9.
dc.relation.bitstream.none.fl_str_mv https://revistas.fucsalud.edu.co/index.php/repertorio/article/download/431/1071
https://revistas.fucsalud.edu.co/index.php/repertorio/article/download/431/1072
https://revistas.fucsalud.edu.co/index.php/repertorio/article/download/431/1094
https://revistas.fucsalud.edu.co/index.php/repertorio/article/download/431/1108
dc.relation.citationedition.spa.fl_str_mv Núm. 3 , Año 2019 : Septiembre - Diciembre
dc.relation.citationendpage.none.fl_str_mv 177
dc.relation.citationissue.spa.fl_str_mv 3
dc.relation.citationstartpage.none.fl_str_mv 171
dc.relation.citationvolume.spa.fl_str_mv 28
dc.relation.ispartofjournal.spa.fl_str_mv Revista Repertorio de Medicina y Cirugía
dc.rights.accessrights.spa.fl_str_mv info:eu-repo/semantics/openAccess
dc.rights.uri.spa.fl_str_mv https://creativecommons.org/licenses/by-nc-sa/4.0/
dc.rights.coar.spa.fl_str_mv http://purl.org/coar/access_right/c_abf2
eu_rights_str_mv openAccess
rights_invalid_str_mv https://creativecommons.org/licenses/by-nc-sa/4.0/
http://purl.org/coar/access_right/c_abf2
dc.format.mimetype.spa.fl_str_mv application/pdf
audio/mpeg
application/xml
text/html
dc.publisher.spa.fl_str_mv Sociedad de Cirugía de Bogotá, Hospital de San José y Fundación Universitaria de Ciencias de la Salud
dc.source.spa.fl_str_mv https://revistas.fucsalud.edu.co/index.php/repertorio/article/view/431
institution Fundación Universitaria de Ciencias de la Salud - FUCS
bitstream.url.fl_str_mv https://repositorio.fucsalud.edu.co/bitstreams/e328388f-ebd5-4c65-b738-8629dbc5e0a1/download
bitstream.checksum.fl_str_mv 698400d2bd496bf49bf99d17c25068bd
bitstream.checksumAlgorithm.fl_str_mv MD5
repository.name.fl_str_mv Repositorio Digital de la Fundación Universitaria de Ciencias de la Salud
repository.mail.fl_str_mv redi@fucsalud.edu.co
_version_ 1814355542276046848
spelling Garnica Benincore, Paola743dea7a2849fbecf9e5fa6e93831bd3500Fuentes París, Sergio785fbe3c76691867eb033dd659055802500Sanabria Ardila , Miguel2387ed1fcb98f5b38ed044d8cedffd3fEspinosa Marrugo, Cristian2d77d7bd64f0cdcecd3f78371b514f30500Rosselli San Martin, Carlos7bb28ddc8f782c24f75dbd854071f591500Osorio Gómez, Nelson William4bda40c84a7f523f90a318bc3f5b405b3002019-10-25 00:00:002022-02-21T20:36:26Z2019-10-252019-10-25 00:00:002022-02-21T20:36:26ZSociedad de Cirugía de Bogotá, Hospital de San José y Fundación Universitaria de Ciencias de la Saludhttps://revistas.fucsalud.edu.co/index.php/repertorio/article/view/431Insuficiencia renal agudaMedios de contrasteAngiografía coronariaMedicina InternaAcute renal insufficiencyContrast mediaCoronary angiographyIncidencia y factores de riesgo asociados con nefropatía inducida por medios de contraste en procedimientos intervencionistas de cardiologíaIncidence and risk factors of contrast-induced nephropathy in interventional cardiology proceduresapplication/pdfaudio/mpegapplication/xmltext/htmlArtículo de revistaJournal articlehttp://purl.org/coar/resource_type/c_6501http://purl.org/coar/resource_type/c_2df8fbb1info:eu-repo/semantics/articleinfo:eu-repo/semantics/publishedVersionTexthttp://purl.org/coar/version/c_970fb48d4fbd8a8510.31260/RepertMedCir.v28.n3.2019.9580121-7372https://repositorio.fucsalud.edu.co/handle/001/23332462-991Xhttps://doi.org/10.31260/RepertMedCir.v28.n3.2019.958spaParfrey P. The clinical epidemiology of contrast-induced nephropathy. Cardiovasc Intervent Radiol. 2005;28 Suppl 2:S3-11. 2. Brar S, Aharonian V, Mansukhani P, et al. Haemodynamic guided fluid for the administration for the prevention of contrast-induced acute kidney injury. The POSEIDON randomized controlled trial . Lancet 2014; 383:1814-23 3. Crimi G, et al. Incidence, pronostic impact and optimal definition of contrast-induced acute kidney injury in consecutive patients with stable or unstable coronary artery disease undergoing percutaneous coronary intervention. Insights from the all-comer PRODIGY trial. Catheter cardiovasc interv. 2015; 86(1):19-27 4. Rihal CS, Textor SC, Grill DE, Berger PB, Ting HH, Best PJ, et al. Incidence and prognostic importance of acute renal failure after percutaneous coronary intervention. Circulation. 2002;105(19):2259-64. 5. Solomon R, Werner C, Mann D, D'Elia J, Silva P. Effects of saline, mannitol, and furosemide on acute decreases in renal function induced by radiocontrast agents. N Engl J Med. 1994;331(21):1416-20. 6. Barrett BJ, Parfrey PS. Prevention of nephrotoxicity induced by radiocontrast agents. N Engl J Med. 1994;331(21):1449-50. 7. Tepel M, van der Giet M, Schwarzfeld C, Laufer U, Liermann D, Zidek W. Prevention of radiographic-contrast-agent-induced reductions in renal function by acetylcysteine. N Engl J Med. 2000;343(3):180-4. 8. Shyu KG, Cheng JJ, Kuan P. Acetylcysteine protects against acute renal damage in patients with abnormal renal function undergoing a coronary procedure. J Am Coll Cardiol. 2002;40(8):1383-8 9. Reza khatami m, nikravan n, salari-far m, davoudi s, et al. A comparison of definitions of contrast-induced nephropathy in patients with normal serum creatinine. Saudi j kidney dis transpl. 2016; 27(1):94-100. 10. Acosta k, Romero J. Cambios recientes en las principales causas de mortalidad en Colombia. Documentos de Trabajo Sobre Economía Regional es una publicación del Banco de la República de Colombia número 209, octubre 2014. 11. Caiazza A, Russo L, Sabbatini M, Russo D. Hemodynamic and tubular changes induced by contrast media. Bio med research international. 2014; 2014:578974. doi: 10.1155/2014/578974 12. Gruberg L, Mehran R, Dangas G, Mintz GS, Waksman R, Kent KM, et al. Acute renal failure requiring dialysis after percutaneous coronary interventions. Catheter Cardiovasc Interv. 2001;52(4):409-16. 13. Tziakas D, Chalikias G, stakos D, et al. Validation of the new risk score to predict contrast-induced nephropathy after percutaneous coronary intervention. Am J cardiol. 2014; 113: 1487-93 14. McCullough PA, Adam A, Becker CR, Davidson C, Lameire N, Stacul F, et al. Risk prediction of contrast-induced nephropathy. Am J Cardiol. 2006;98(6A):27K-36K. 15. Zhang B, Liang L, Chen W, et al. The efficacy of sodium bicarbonate in preventing contrast-induced nephropathy in patients with pre-existing renal insufficiency: a meta analysis. BMJ open. 2015; 5(3): 1-12. 16. Iakovou I, Dangas G, Mehran R, Lansky AJ, Ashby DT, Fahy M, et al. Impact of gender on the incidence and outcome of contrast-induced nephropathy after percutaneous coronary intervention. J Invasive Cardiol. 2003;15(1):18-22. 17. Bouzas-Mosquera A, Vázquez-Rodríguez JM, Calviño-Santos R, Peteiro-Vázquez J, Flores-Ríos X, Marzoa-Rivas R, et al. [Contrast-induced nephropathy and acute renal failure following emergent cardiac catheterization: incidence, risk factors and prognosis]. Rev Esp Cardiol. 2007;60(10):1026-34. 18. Weisbord SD, Gallagher M, Jneid H, Garcia S, Cass A, Thwin SS, et al. Outcomes after Angiography with Sodium Bicarbonate and Acetylcysteine. N Engl J Med. 2018;378(7):603-14. 19. McCullough PA, Choi JP, Feghali GA, Schussler JM, Stoler RM, Vallabahn RC, et al. Contrast-Induced Acute Kidney Injury. J Am Coll Cardiol. 2016;68(13):1465-73. 20. Scharnweber T, Alhilali L, Fakhran S. Contrast-Induced Acute Kidney Injury: Pathophysiology, Manifestations, Prevention, and Management. Magn Reson Imaging Clin N Am. 2017;25(4):743-53. 21. Madsen TE, Pearson RR, Muhlestein JB, Lappé DL, Bair TL, Horne BD, et al. Risk of nephropathy is not increased by the administration of larger volume of contrast during coronary angiography. Crit Pathw Cardiol. 2009;8(4):167-71. 22. Carnevalini M, et al. Nefropatía por constraste en el síndrome coronario agudo. Medicina. 2011; 71(5):441-448. 23. Nikolsky E, Mehran R, Lasic Z, Mintz GS, Lansky AJ, Na Y, et al. Low hematocrit predicts contrast-induced nephropathy after percutaneous coronary interventions. Kidney Int. 2005;67(2):706-13. 24. Freeman RV, O'Donnell M, Share D, Meengs WL, Kline-Rogers E, Clark VL, et al. Nephropathy requiring dialysis after percutaneous coronary intervention and the critical role of an adjusted contrast dose. Am J Cardiol. 2002;90(10):1068-73. 25. Garfinkle M, et al. Incidence of CT contrast agent- induced nephropathy a more accurate estimation. AJR. 2015; 204: 1146-51 26. Roy P, Raya V, Okabe T, Pinto Slottow TL, Steinberg DH, Smith K, et al. Incidence, predictors, and outcomes of post-percutaneous coronary intervention nephropathy in patients with diabetes mellitus and normal baseline serum creatinine levels. Am J Cardiol. 2008;101(11):1544-9. 27. Rear R, Bell RM, Hausenloy DJ. Contrast-induced nephropathy following angiography and cardiac interventions. Heart. 2016;102(8):638-48. 28. Tsai TT, Patel UD, Chang TI, Kennedy KF, Masoudi FA, Matheny ME, et al. Contemporary incidence, predictors, and outcomes of acute kidney injury in patients undergoing percutaneous coronary interventions: insights from the NCDR Cath-PCI registry. JACC Cardiovasc Interv. 2014;7(1):1-9.https://revistas.fucsalud.edu.co/index.php/repertorio/article/download/431/1071https://revistas.fucsalud.edu.co/index.php/repertorio/article/download/431/1072https://revistas.fucsalud.edu.co/index.php/repertorio/article/download/431/1094https://revistas.fucsalud.edu.co/index.php/repertorio/article/download/431/1108Núm. 3 , Año 2019 : Septiembre - Diciembre177317128Revista Repertorio de Medicina y Cirugíainfo:eu-repo/semantics/openAccesshttps://creativecommons.org/licenses/by-nc-sa/4.0/http://purl.org/coar/access_right/c_abf2PublicationOREORE.xmltext/xml2689https://repositorio.fucsalud.edu.co/bitstreams/e328388f-ebd5-4c65-b738-8629dbc5e0a1/download698400d2bd496bf49bf99d17c25068bdMD51001/2333oai:repositorio.fucsalud.edu.co:001/23332024-02-02 13:07:21.449https://creativecommons.org/licenses/by-nc-sa/4.0/metadata.onlyhttps://repositorio.fucsalud.edu.coRepositorio Digital de la Fundación Universitaria de Ciencias de la Saludredi@fucsalud.edu.co